Reduced mortality in cystic fibrosis pat
β
Gregory S. Sawicki; James E. Signorovitch; Jie Zhang; Dominick Latremouille-Viau
π
Article
π
2011
π
John Wiley and Sons
π
English
β 110 KB
## Abstract ## Background Though tobramycin inhalation solution has been used for over a decade to improve lung function and reduce exacerbations in patients with cystic fibrosis (CF), its effects on mortality have not been wellβdescribed. This study aimed to assess the association between use of